UnitedHealth Group Optumrx — Earnings from operations increased by 7.5% to $1.55B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $1.54B to $1.55B. Over 3 years (FY 2021 to FY 2024), Optumrx — Earnings from operations shows an upward trend with a 12.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Increasing earnings indicate strong operational performance and effective cost control, while decreasing earnings signal margin pressure or rising service costs.
The profit generated by the pharmacy benefit management segment after deducting operating expenses from total revenues....
Equivalent to segment operating income used by analysts to compare profitability across healthcare service segments.
unh_segment_optum_rx_earnings_from_operations| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $993.00M | $1.01B | $1.24B | $939.00M | $1.04B | $1.08B | $1.37B | $1.06B | $1.21B | $1.26B | $1.59B | $1.15B | $1.41B | $1.54B | $1.74B | $1.32B | $1.44B | $1.55B |
| QoQ Change | — | +1.9% | +22.5% | -24.3% | +11.2% | +3.5% | +26.9% | -22.7% | +13.8% | +4.2% | +26.7% | -28.0% | +22.6% | +9.8% | +12.6% | -24.2% | +9.3% | +7.5% |
| YoY Change | — | — | — | — | +5.1% | +6.8% | +10.6% | +12.9% | +15.5% | +16.3% | +16.0% | +8.2% | +16.6% | +22.8% | +9.2% | +14.9% | +2.5% | +0.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.